
Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept helping patients years later.
On social media, in honor of Thanksgiving, CURE® recently asked its readers to share what they are most thankful for this holiday season.
For more news on cancer updates, research and education, don’t forget to






